MedTrace Logo

The Heidelberg Engineering ANTERION Anterior Segment Cornea and IOL Precision and Agreement Study

NCT04130490 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 176

Last updated 2024-04-30

No results posted yet for this study

Summary

This is a prospective clinical study that will be conducted at one clinical site located in the United States to assess anterior segment parameters with the ANTERION

Conditions

  • Cataract
  • Healthy Eye
  • Cornea Abnormality
  • Post-Keratorefractive Surgery
  • IOL

Interventions

DEVICE

ANTERION

3 repeat measurements performed with two of the ANTERION acquisition types and 3 repeat measurements performed with 2 acquisition types of the references devices

Sponsors & Collaborators

  • Heidelberg Engineering GmbH

    lead INDUSTRY

Principal Investigators

  • Mitchell Dul · State University of New York College of Optometry

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-11
Primary Completion
2023-10-30
Completion
2023-12-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04130490 on ClinicalTrials.gov